Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

Jay H. Traverse, Timothy D Henry, Douglas E. Vaughn, Stephen G. Ellis, Carl J. Pepine, James T. Willerson, David X.M. Zhao, Linda B. Piller, Marc S. Penn, Barry J. Byrne, Emerson C. Perin, Adrian P. Gee, Antonis K. Hatzopoulos, David H McKenna, John R. Forder, Doris A. Taylor, Christopher R. Cogle, Rachel E. Olson, Beth C. Jorgenson, Shelly L. SayreRachel W. Vojvodic, David J. Gordon, Sonia I. Skarlatos, Lemuel A. Moye', Robert D. Simari

Research output: Contribution to journalArticlepeer-review

62 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction'. Together they form a unique fingerprint.

Medicine & Life Sciences